B
Bongshin Lee
Researcher at Microsoft
Publications - 258
Citations - 12105
Bongshin Lee is an academic researcher from Microsoft. The author has contributed to research in topics: Visualization & Data visualization. The author has an hindex of 55, co-authored 245 publications receiving 9790 citations. Previous affiliations of Bongshin Lee include Children's National Medical Center & University of Maryland, College Park.
Papers
More filters
Proceedings ArticleDOI
Understanding quantified-selfers' practices in collecting and exploring personal data
TL;DR: A qualitative and quantitative analysis of 52 video recordings of Quantified Self Meetup talks to understand what they did, how they did it, and what they learned, and several common pitfalls to self-tracking are highlighted.
Proceedings ArticleDOI
Home automation in the wild: challenges and opportunities
TL;DR: The long term experience of households with home automation illustrates four barriers that need to be addressed before home automation becomes amenable to broader adoption, and provides several directions for further research.
Proceedings ArticleDOI
Task taxonomy for graph visualization
TL;DR: A list of tasks commonly encountered while analyzing graph data is suggested and it is demonstrated how all complex tasks could be seen as a series of low-level tasks performed on those objects.
Journal ArticleDOI
Effectiveness of Animation in Trend Visualization
TL;DR: This paper proposes two alternative trend visualizations that use static depictions of trends: one which shows traces of all trends overlaid simultaneously in one display and a second that uses a small multiples display to show the trend traces side-by-side.
Journal ArticleDOI
Naturally occurring dominant resistance mutations to hepatitis c virus protease and polymerase inhibitors in treatment-naive patients
Thomas Kuntzen,Joerg Timm,Andrew Berical,Niall Lennon,Aaron M. Berlin,Sarah Young,Bongshin Lee,David Heckerman,Jonathan M. Carlson,Laura L. Reyor,Marianna Kleyman,Cory M. McMahon,Christopher E. Birch,Julian Schulze zur Wiesch,Timothy Ledlie,Michael Koehrsen,Chinnappa D. Kodira,Andrew Roberts,Georg M. Lauer,Hugo R. Rosen,Florian Bihl,Andreas Cerny,Ulrich Spengler,Zhimin Liu,Arthur Y. Kim,Yanming Xing,Arne Schneidewind,Margaret A. Madey,Jaquelyn Fleckenstein,Vicki M. Park,James E. Galagan,Chad Nusbaum,Bruce D. Walker,Bruce D. Walker,Gerond Lake-Bakaar,Eric S. Daar,Ira M. Jacobson,Edward D. Gomperts,Brian R. Edlin,Sharyne M. Donfield,Raymond T. Chung,Andrew H. Talal,Tony N. Marion,Bruce W. Birren,Matthew R. Henn,Todd M. Allen +45 more
TL;DR: Naturally occurring dominant STAT‐C resistance mutations are common in treatment‐naïve patients infected with HCV genotype 1, and their influence on treatment outcome should be characterized to evaluate possible benefits of drug resistance testing for individual tailoring of drug combinations when treatment options are limited due to previous nonresponse to peginterferon and ribavirin.